FDA Inspection 1162402 — Orthority Corporation
The FDA completed an inspection of Orthority Corporation on Feb 8, 2022 in Caguas, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 8, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Caguas, PR (United States)